Feb 13 (Reuters) - Berkshire Hathaway BRKa.N said on Thursday night it sold 203,091 shares of DaVita DVA.N, reducing its stake in the kidney dialysis services provider to about 35.89 million shares, a 45% stake worth nearly $6.4 billion.
In a regulatory filing, Berkshire said the February 11 sale was required pursuant to a share repurchase agreement, under which DaVita agreed on a quarterly basis to buy back enough shares to reduce Berkshire's ownership stake to 45%.
(Reporting by Jonathan Stempel in New York; Editing by Sandra Maler)
((jon.stempel@thomsonreuters.com; +1 646 223 6317; Reuters Messaging: jon.stempel.thomsonreuters.com@reuters.net))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。